BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37334737)

  • 1. Integrated transcriptomics reveals the brain and blood biomarkers in Alzheimer's disease.
    Yu H; Wang F; Wu JJ; Gong J; Bi S; Mao Y; Jia D; Chai GS
    CNS Neurosci Ther; 2023 Dec; 29(12):3943-3951. PubMed ID: 37334737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification.
    Zhong H; Zhou X; Uhm H; Jiang Y; Cao H; Chen Y; Mak TTW; Lo RMN; Wong BWY; Cheng EYL; Mok KY; Chan ALT; Kwok TCY; Mok VCT; Ip FCF; Hardy J; Fu AKY; Ip NY
    Alzheimers Dement; 2024 Apr; 20(4):2469-2484. PubMed ID: 38323937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer's disease in mild cognitive impairment patients.
    Qian XH; Liu XL; Chen SD; Tang HD
    Front Immunol; 2022; 13():986346. PubMed ID: 36159817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic Analysis of Lipid Metabolism Genes in Alzheimer's Disease: Highlighting Pathological Outcomes and Compartmentalized Immune Status.
    Sun Y; Jiang M; Long X; Miao Y; Du H; Zhang T; Ma X; Zhang Y; Meng H
    J Mol Neurosci; 2024 May; 74(2):55. PubMed ID: 38776015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
    Chen M; Xia W
    J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of dysregulated genes and pathways of different brain regions in Alzheimer's disease.
    Wang Y; Wang Z
    Int J Neurosci; 2020 Nov; 130(11):1082-1094. PubMed ID: 32019384
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioinformatics analysis of differentially expressed genes and identification of an miRNA-mRNA network associated with entorhinal cortex and hippocampus in Alzheimer's disease.
    Li H; Zou L; Shi J; Han X
    Hereditas; 2021 Jul; 158(1):25. PubMed ID: 34243818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
    PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Autophagy-Related Candidate Genes in the Early Diagnosis of Alzheimer's Disease and Exploration of Potential Molecular Mechanisms.
    Wang J; Huo X; Zhou H; Liu H; Li X; Lu N; Sun X
    Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38329682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer's disease through machine learning algorithms.
    Jiang L; Wang Q; Jiang Y; Peng D; Zong K; Li S; Xie W; Zhang C; Li K; Wu Z; Huang Z
    Clin Chim Acta; 2024 Apr; 557():117892. PubMed ID: 38537674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Expression Profiles Revealed by Transcriptomic Analysis in Peripheral Blood Mononuclear Cells of Alzheimer's Disease Patients.
    Leandro GS; Evangelista AF; Lobo RR; Xavier DJ; Moriguti JC; Sakamoto-Hojo ET
    J Alzheimers Dis; 2018; 66(4):1483-1495. PubMed ID: 30400085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Blood Biomarkers CXCL12 and TNFRSF13C Associate with Cerebrospinal Fluid Biomarkers and Infiltrating Immune Cells in Alzheimer Disease.
    Wu Q; Kong W; Wang S
    J Mol Neurosci; 2021 Jul; 71(7):1485-1494. PubMed ID: 33687622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking the association between circRNAs and Alzheimer's disease progression by multi-tissue circular RNA characterization.
    Lo I; Hill J; Vilhjálmsson BJ; Kjems J
    RNA Biol; 2020 Dec; 17(12):1789-1797. PubMed ID: 32618510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
    Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
    BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Bioinformatic Analysis and Validation Identifies Immune Microenvironment-Related Potential Biomarkers in Alzheimer's Disease.
    Yang F; Zhang N; Ou GY; Xu SW
    J Prev Alzheimers Dis; 2024; 11(2):495-506. PubMed ID: 38374756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.